According to sources, the price guidance for the latest health insurance-linked security (ILS) from Aetna, Vitality Re VI Ltd. (Series 2015-1), has not changed as the transaction approaches completion.
Investor sources told Artemis that the sixth Vitality Re medical benefit ratio linked ILS deal from Aetna has not seen a tightening of guidance or any change in the range that the deal launched with as yet. In fact the deal’s bookrunner Goldman Sachs is said to have reiterated the launch guidance to investors today.
The notes continue to be marketed to investors with the Class A notes offered with a coupon range of 1.65% to 2.15%, while the riskier Class B notes continue to be offered with guidance of 2.25% to 2.75%.
The Vitality Re VI transaction is slated to price early this week. We will update you as and when further updates become available and as the transaction reaches completion.
Read all about this transaction in the Artemis Deal Directory entry, Vitality Re VI Ltd. (Series 2015-1), and in our previous articles covering its launch:
– Aetna launches new Vitality Re VI health insurance linked ILS.
– S&P explains volatility in Vitality Re ILS, but pandemic remains the tail.
View all of our Artemis Live video interviews and subscribe to our podcast.
All of our Artemis Live insurance-linked securities (ILS), catastrophe bonds and reinsurance video content and video interviews can be accessed online.
Our Artemis Live podcast can be subscribed to using the typical podcast services providers, including Apple, Google, Spotify and more.
